BVT:JSEBidvest Group Limited Analysis
Data as of 2026-09-05 - not real-time
ZAC 23,000.00
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
At ZAC 23,000.00, The Bidvest Group Limited shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 1.2%. RSI sits at 39.6, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at ZAC 22,263.00 up to resistance at ZAC 25,095.00.
Multiples put this in undervalued territory: 12.7 times earnings against the sector's 28.5. The average analyst target implies 27.0% above today's level. Revenue is growing at 2.2% on a 4.7% profit margin. The 4.23% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 20.1%, a beta of 0.14 and a maximum drawdown of 12.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 6/10 conviction over the longer horizon.
Multiples put this in undervalued territory: 12.7 times earnings against the sector's 28.5. The average analyst target implies 27.0% above today's level. Revenue is growing at 2.2% on a 4.7% profit margin. The 4.23% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 20.1%, a beta of 0.14 and a maximum drawdown of 12.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 6/10 conviction over the longer horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 23704.05
- MACD momentum is negative
- RSI at 39.6 is in neutral territory
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 12.7 versus sector average of 28.5
- Trading below the 200-day average of 23704.05
- Analyst targets imply +27.0% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 12.7 versus sector average of 28.5
- Analyst targets imply +27.0% versus the current price
- Return on equity of 15.4%
Key Metrics & Analysis
Financial Health
Revenue Growth2.20%
Profit Margin4.72%
P/E Ratio12.7
ROE15.41%
ROA6.12%
Debt/Equity96.23
P/B Ratio2.0
Op. Cash FlowZAC12.5B
Free Cash FlowZAC7.8B
Industry P/E28.5
Technical Analysis
TrendNeutral
RSI39.6
SupportZAC 22,263.00
ResistanceZAC 25,095.00
MA 20ZAC 23,870.95
MA 50ZAC 23,972.76
MA 200ZAC 23,704.05
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48
Valuation
Fair ValueZAC 21,895.54
Target PriceZAC 29,219.29
Upside/Downside27.04%
GradeUndervalued
TypeValue
Dividend Yield4.23%
Risk Assessment
Beta0.14
Volatility20.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.